Skip to main content

Advertisement

SpringerLink
Log in

Ribavirin: A clinical overview

  • Published:
European Journal of Epidemiology Aims and scope Submit manuscript

Abstract

Ribavirin, a broad spectrum, non-interferon-inducing virustatic chemotherapeutic agent, demonstrates activity against a wide range of RNA and DNA viruses, including the retrovirus known to cause the acquired immune deficiency syndrome. The drug's proposed mechanism of action, as well as pharmacokinetics are discussed, and preclinical toxicity, safety and clinical efficacy studies are presented.

To date, the best success has occurred in the use of ribavirin to treat respiratory syncytial virus infection in infants and young children and to treat influenza A and B virus infections in young adults. Viral infections, particularly viral pneumonia, are often life-threatening in infants with severe combined immunodeficiency disease (SCID), and ribavirin aerosol has been used successfully to treat respiratory syncytial virus and parainfluenza virus infection of immunodeficient children.

Special note is taken of ribavirin's clinical benefit in treating severe and life-threatening infections caused by the Lassa fever virus and the significant improvement over either the use of immune plasma or supportive therapy alone. Indeed, ribavirin thus emerges as the first antiviral drug that is able to reduce mortality in a highly lethal systemic disease by more than 90%.

Additional studies demonstrate the drug's efficacy in acute viral hepatitis, herpesvirus infections, and measles. Controlled clinical trials are underway to test the drug in patients infected with the AIDS virus.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Allen, L.B., (1980): Review of In Vivo Efficacy of Ribavirin. In: Smith, R.A., Kirkpatrick, W. (eds.), Ribavirin: A Broad Spectrum Antiviral Agent. -Academic Press, London, New York, pp. 43–58.

    Google Scholar 

  2. Allen, L.B., Wolf, S.M., Hintz, C.J., Huffman, J.H., Siduwell, R.W. (1977): Effect of Ribavirin on Type 2 Herpesvirus hominis (HVH/2) In Vitro and In Vivo. - Ann. N.Y. Acad. Sci., 284: 247–253.

    Google Scholar 

  3. Appleyard, G., Maber, H.B. (1975): A Plaque Assay for the Studv of Infuenza Virus Inhibitors. - J. Antimicrob. Chemother. [Suppl.], 1: 49–53.

    Google Scholar 

  4. Arensman, I.B., Dominik, J.W., Hilmas, D.E., (1977): Effects of Small-Particle Aerosols of Rimantadine and Ribavirin on Arterial Blood pH and Gas Tensions and Lung Water Content of A2 Influenza-Infected Mice. - Antimicrob. Agents Chemother., 12: 40–46.

    Google Scholar 

  5. Banks, G., Fernandez, H. (1984): Clinical Use of Ribavirin in Measles: A Summarized Review. In: Smith, R.A., Knight, V., Smith, J.A.D. (eds.), Clinical Applications of Ribavirin. - Academic Press, New York, pp. 203–209.

    Google Scholar 

  6. Bekesi, J.G., Roboz, J.P., Zimmerman, E., HollandJ.F. (1976): Treatment of Spontaneous Leukemia in AKR Mice with Chemotherapy, Immunotherapy, or Interferon. - Cancer Res., 36: 631–639.

    Google Scholar 

  7. Bierman, S.M., Kirkpatrik, W., Fernandez, H. (1981): Clinical Efficacy of Ribavirin in the Treatment of Genital Herpes Simplex Virus Infection. -Chemotherapy, 27: 139–145.

    Google Scholar 

  8. Browne, M.J. (1979): Mechanism and Specificity of Action of Ribavirin. - Antimicrob. - Agents Chemother., 15: 747–753.

    Google Scholar 

  9. Canonico, P.G., Little, J.S.Jahrling, P.B., StephenE.L. (1980): Molecular Aspects of the Antiviral Activity of Ribavirin on Venezuelan Equine Encephalomyelitis Virus. In: Nelson, J.D., Grassi, C., (eds.), Current Chemotherapy and Infectious Disease. - Am. Soc. Microbial., Washington, pp. 1370–1372.

    Google Scholar 

  10. Canonico, P.G. (1983): Ribavirin: A review of Efficacy, Toxicity and Mechanisms of Antiviral Activity. In: (F.E. Hahn ed.), Antibiotics, Modes and Mechanisms of Microbial Growth Inhibitors. -Spiringer-Verlag, Berlin, vol. 6, pp. 161–186.

    Google Scholar 

  11. Canonico, P.G., Kende, M., Huggins, J.W. (1984): The Toxicology and Pharmacology of Ribavirin in Experimental Animals. In: Smith, R.A., Knight V., Smith, J.A.D. (eds), Clinical applications of ribavirin. - Academic Press, New York, pp. 65–78.

    Google Scholar 

  12. Catlin, D.M., Smith, R.A.Samuels, A.I. (1980): 14C Ribavirin: Distribution and Pharmacokinetic Studies in Rats, Baboons and Man: In: Smith, R.A., Kirckpatrick, W. (eds), Ribavirin: A Broad Spectrum Antiviral Agent. - Academic Press, New York, pp. 83–98.

    Google Scholar 

  13. Cohen, A., Togo, Y., Khakoo, R.et al. (1976): Comparative Clinical and Laboratory Evaluation of the Prophylactic Capacity of Ribavirin, Amantidine Hhdrochloride, and Placebo in Induced Human Infuenza Type A. - J. Infect. Dis., 1335: A114–20.

    Google Scholar 

  14. Connor, J.D., Minkoff, D.I. (1980): Clinical Use of Ribavirin and the Treatment of Herpes Zoster in Otherwise Normal Adults. In: Smith, R.A., Kirkpatrick, W. (eds), Ribavirin: A Broad Spectrum Antiviral Agent. - Academic Press, New York, pp. 185–199.

    Google Scholar 

  15. Connor, J.D., Hintz, M., VanDyke, R., McCormickJ.B., McIntosh, K. (1984): Ribavirin Pharmacokinetics in Children and Adults During Therapeutic Trials. In: Smith, R.A., Knight, V., Smith J.A.D. (eds), Clinical Applications of Ribavirin. -Academic Press, New York, pp. 107–123.

    Google Scholar 

  16. DeClercq, E., Luczak, M., Shugar, D., TorrenceP.F., Waters, J.A., Witkop, B. (1976): Effect of Cytosine Arabinoside, Iododeoxyuridine, Ethyldeoxyuridine, Thiocyanatofeoxyuridine, and Ribavarin on Tail Lesion Formation in Mice Inflected with Vaccinia Virus. - Proc. Soc. Exp. Biol. Med., 151: 487–490.

    Google Scholar 

  17. Descamps, J., DeClercq, E. (1977): Broad Spectrum Antiviral Activity of Pyrazofurin (Pyrazomycin). In: Siegenthaler, W., Luthy, R. (eds), Current Chemotherapy.- Am. Soc. Microbiol., Washington, 1: 354–357.

    Google Scholar 

  18. Dowling, J.N., Postic, B., Guevarra, L.O. (1976): Effect of Ribavirin on Murine Cytomegalovirus Infection. - Antimicrob. Agents Chemother., 10: 809–813.

    Google Scholar 

  19. Durr, F.E., Lindh, H.F., (1975): Efficacy of 1-β-D-Ribofuranosyl-1,2,4-Triazole-3-Carboxamide Against Influenza Virus Infections in Mice. - Antimicrob. Agents Chemother., 7: 582–586.

    Google Scholar 

  20. Eddy, G.A., Peters, C.J., Meadors, G., Cole, F.E.Jr. (1981): Rift Valley Fever Vaccine for Humans. -Contrib. Epidemiol. Biostatist., 3: 124–141.

    Google Scholar 

  21. Eidson, C.S., Than, V.T., Kleven, S.H. (1974): The In Vitro and In Vivo Effect of Chemotherapeutic Agents on the Marek's Disease Herpesvirus of Chickens. - Poultry Sci., 53: 1533–1538.

    Google Scholar 

  22. Eriksson, B., Helgstrand, E., Johansson, N.G., Larsson, A., Misirony, A., Noren, J.O., Philipson, L., Stenberg, K., Stening, G., Stridh, S., Oberg, B. (1977): Inhibition of Infuenza Virus Ribonucleic Acid Polymerase by Ribavirin Triphosphate. - Antimicrob. Agents Chemother., 11: 946–951.

    Google Scholar 

  23. Esper-Dib, S., Scholz, I., Arroyo, C. (1977): Tratamiento de la Gingivoestomatitis Herpetiica —Estudio Doble Ciego Entre Ribavirin y Placebo. -Sem. Med., 92: 245–250.

    Google Scholar 

  24. Fernandez, H. (1980): Ribavirin: A Summary of Clinical Trials - Herpes Genitalis and Maesles. In: Smith, R.A., Kirkpatrick, W. (eds), Ribavirin: A broad spectrum antiviral agent. - Academic Press, London, New York, pp. 215–230.

    Google Scholar 

  25. Frame, J.D., Baldwin, J.M.Jr., Gocki, D.J. and Troup, J.M. (1970): Lassa Fever, a New Virus Disease of Man From West Africa. I. Clinical Description and Pathologic Findings. - Am. J. Trop. Med. Hyg., 19: 670–676.

    Google Scholar 

  26. Galvao, P.A.A., Castro, I.O. (1977): Ann. N.Y. Acad. Sci., 284: 278–283.

    Google Scholar 

  27. Gelfand, E.W., McCurdy, D., Pander, Rao, C., Middleton, P.J. (1983): Ribavirin Treatment of Viral Pneumonitis in Severe Combined Immunodeficiency Disease. - Lancet, 2: 732–733.

    Google Scholar 

  28. Goswami, B.B., Borek, E., Sharma, O.K., Fujitaki, J., Smith, R.A. (1979): The Broad Spectrum Antiviral Agent Ribavirin Inhibits Capping of mRNA. -Biochem. Biophys. Res. Commun., 89: 830–836.

    Google Scholar 

  29. Hahn, F.E. (1979): Virazole (ribavirin). In: Hahn F.E. (ed), Mechanism of Action of Antieukaryotic and Antiviral Compounds. Springer, Berlin, Heidelberg, New York, 2: 439–456.

    Google Scholar 

  30. Hall, C.B., Walsh, E.E., Hruska, J.F., Betts, R.F., HallW.J. (1983): Ribavirin Treatment of Experimental Respiratory Syncytial Viral Infection. - J. Amer. Med. Assoc., 249(19): 2666–2670.

    Google Scholar 

  31. Hall, C.B., McBride, J.T., Walsh, E.E., Bell, D.M., Gala, C., Hildreth, S., Ten Eyck, L.G., Hall, W.J. (1983): Aerosolized Ribavirin Treatment of Infants with Respiratory Syncytial Viral Infection.- N. Engl. J. Med., 308(24): 1443–1447.

    Google Scholar 

  32. Harris, S., Robins, R.K. (1980): Ribavirin: Structure and Antiviral Activity Relationships. In: Smith R.A., Kirkpatrick, W. (eds), Ribavirin: A Broad Spectrum Antiviral Agent. - Academic Press, London, New York, pp. 1–21.

    Google Scholar 

  33. Hillyard, I.W. (1980): The preclinical toxicology and safety of ribavirin. In: Smith, R.A., Kirkpatrick W. (eds) Ribavirin: A Broad Spectrum Antiviral Agent. - Academic Press, New York, pp. 59–72.

    Google Scholar 

  34. Hoffmann S.H. (1985) : Personal Communication.

  35. Huffman, J.H., Sidwell, R.W., Khare, G.P.WitkowskiJ.T., Allen, L.B.Robins, R.K. (1973): In vitro effect of 1-β-D-Ribofuranosyl-1,2,4-Triazole-3-Carboxamide (Virazole, ICN 1229) on Deoxribonucleic Acid and Ribonucleic Acid Viruses. - Antimicrob. Agents Chemother., 3: 235–241.

    Google Scholar 

  36. Huggins D., Pereira G.J.M. (1977): Rev. Bras. Med., 34 (5).

  37. Huggins, J.M., Jahrling, P., Kende, M. and CanonicoP.G. (1984): Efficacy of Ribavirin Against Virulent RNA Virus Infections. In: Smith, R.A., Knight, V. and Smith, J.A.D. (eds), Clinical Applications of Ribavirin. - Academic Press, New York, pp. 49–63.

    Google Scholar 

  38. Jacobi, P., Hoffman, K., Arend, P., Muckter, H. (1977): In vivo evaluation of the Antiviral Efficacy of Ribavirin Against Influenza, Hepatitis, Herpes, and Vaccinia Infections in Mice. In: Siegenthaler W., Luthy, R. (eds), Current Chemotherapy. - Am. Soc. Microbiol., Washington, 1: 340–343.

    Google Scholar 

  39. Jahrling, P.B., Hesse, R.A., Eddy, G.A., Johnson, K.M., Callis, R.T., Stephen, E.L. (1980): Lassa Virus Infection In Rhesus Monkeys: Pathogenesis and Treatment with Ribavirin. - J. Infect. Dis., 141: 580–589.

    Google Scholar 

  40. Jahrling, P.B., Peters, J., and Stephen, E.L. (1984): Enhanced Treatment of Lassa Fever by Immune Plasma Combined With Ribavirin in Cynomolgus Monkeys. - J. Infect. Dis., 149: 420–427.

    Google Scholar 

  41. Jain, S., Thomas, H.C., Oxford, J.S., Sherlock, S. (1978): J. Antimicrob. Chemoth., 4: 376–373.

    Google Scholar 

  42. Jolley, W.B., Suchil, C. (1984): Effects of Ribavirin on the Immune System (second Report). In: Smith, R.A., Knight, V., Smith, J.A.D. (eds), Clinical Applications of Ribavirin. - Academic Press, New York, pp. 93–96.

    Google Scholar 

  43. Katz, E., Margalith, E., Winer, B. (1976): Inhibition of Vaccinia Virus Growth by the Nucleoside Analogue 1-β-D-Ribofuranosyl-1, 2, 4-Triazole-3-Carboxamide (Virazole, Ribavirin). J. Gen. Virol., 32: 327–330

    Google Scholar 

  44. Khare, G.P., Sidwell, R.W., Witkowski, J.T., SimonL.M., Robins, R.K. (1973): Suppression by 1-β-D-Ribofurano:syl-1, 2, 4-Triazole-3-Carboxamide (Virazole, ICN 1229) of Influenza Virus-Induced Infections in Mice. - Antimicrob. Agents Chemother, 3: 517–522.

    Google Scholar 

  45. Knight, V., McClung, H.W., Wilson, S.Z., Waters, B.K., Qualers, J.M., Cameron, R.W., Greggs, S.E., ZerwasJ.M., Couch, R.B. (1981): Ribavirin Small-Particle Aerosol Treatment of Influenza. - Lancet, 2: 945–949.

    Google Scholar 

  46. Kumta, N.B., Antani, D.N. (1983): Pediatrics, 20: 99–103.

    Google Scholar 

  47. Larsson, A., Stenberg, K., Oberg, B. (1978): Reversible Inhibition of Cellular Metabolism by Ribavirin. - Antimicrob. Agents Chemother, 13: 154–158.

    Google Scholar 

  48. Latonio A.A., Limson B.M., Ramos T.T. (1978): On File at Viratek, Inc.

  49. Lorenco, R., Camargo, M.J., Castro, I.O. (1977): Revista Medica Brasileira, 33: 401–403.

    Google Scholar 

  50. Lowe, J.K., Brox, L., Henderson, J.F. (1977): Consequences of Inhibition of Guanine Nucleotide Synthesis by Mycophenolic Acid and Virazole. - Cancer Res., 37: 736–743.

    Google Scholar 

  51. Magnussen, C.R., Douglas, R.G., Betts, R.F., RothF.K., Meagher, M.P. (1977): Double-Blind Evaluation of Oral Ribavirin (Virazole) in Experimental Influenza A Virus Infection in Volunteers. - Antimicrob. Agents Chemotehr., 12: 498–502.

    Google Scholar 

  52. Mc Clung, H.W., Knight, V., Gilbert, B.E., WilsonS.Z., Quarles, J.M., Divine, G.W. (1983): Ribavirin Aerosol Treatment of Influenza B Virus Infection.- J. Amer. Med. Assoc., 249(19): 2671–2674.

    Google Scholar 

  53. McCorinick, J.B., Webb, P.A., Johnson, K.M., (1980): Lassa Immune Plasma and Ribavirin in the Therapy of Acute Lassa Fever. In: Smith, R.A., Kirkpatrick W. (eds), Ribavirin: A Broad Spectrum Antiviral Agent. - Academic Press, London, New York, p. 213.

    Google Scholar 

  54. McCormick, J.B., Getchell, J.P., Mitchell, S.W.et al. (1984): Ribavirin Suppress Replication of Lymphadenopathy-Associated Virus in Cultures of Human Adult T Lymphocytes. - Lancet, ii: 1367–69.

    Google Scholar 

  55. McCormick, J.B.Webb, P.A., Johnson, K.M. and Scribner, C.S. (1984): Chemotherapy of Acute Lassa Fever with Ribavirin. In: Smith, R.A., Knight, V., Smith, J.A.D. (eds). Clinical Application of Ribavirin.- Accademic Press, New York, pp. 49–63.

    Google Scholar 

  56. McCormick J.B., King I., Webb P.A., Johnson K.M. and Scribner C.S., Smith E.S., Craven R.B., O-Sullivan R. and Belmont-Williams R. (1985): Lassa Fever: Efficacy of Therapy with Ribavirin. - N. Engl. J. Med., (in press).

  57. McCormick J.B et al. (1985): J. of Infect Dis., (in press).

  58. McIntosh, K., Kurachek, S.C., Cairns, L.M., BurnsJ.C., Goodspeed, B. (1984): Treatment of Respiratory Viral Infection in an Immunodeficient Infant with Ribavirin Aerosol. - Amer. J. Dis. Children, 138: 305–308.

    Google Scholar 

  59. Menzell, G., Steuz, E. (1978): Wirkungen Von Virazole (Ribavirin) in Virus-Prokaryonten-Systemen.- Acta. Microbiol. Acad. Sci. Hung., 25: 11–15

    Google Scholar 

  60. Monath, T.P., Mertens, P.E., Patton, R., Moser, C.R., Baum, J.J., Pinneo, L., Gary, G.W.Jr. and KisslingR.E. (1973): A Hospital Epidemic of Lassa Fever in Zorzor, Liberia, March-April, 1972. - Am. J. Trop. Med. Hyg., 22: 773–780.

    Google Scholar 

  61. Mosley J.W., Redeker A.G. (1974): On File at Viratek, Inc.

  62. Muller, E.W.G., Maidhof, A., Taschner, H., Zahn, R.K. (1977): Virazole (1-β-D-Ribofuranosly-1, 2, 4-Triazole-3-Carboxamide) a Cytostatic Agent. - Biochem. Pharmacol., 26: 1071–1075.

    Google Scholar 

  63. Muthukrishnan, S., Moss, B., Cooper, J.A., MaxwellE.S. (1978): Influence of 5′-Terminal Cap Structure on the Initiation of Translation of Vaccinia Virus mRNA. - J. Biol. Chem., 253: 1710–1715.

    Google Scholar 

  64. Nishimura, H., Mayama, M., Komatsu, Y., Kato, H., Shimaoka, N., Tanaka, Y., (1964): Showdomycin, a New Antibiotic From a Streptomyces Sp. - J. Antibiot., 17: 148–155.

    Google Scholar 

  65. Odelola, H.A. (1977): Antiviral Activity of Virazole on Replication of Viruses Isolated in Nigeria. In: Siegenthaler, W., Luthy, R. (eds), Current Chemotherapy.- Am. Soc. Microbiol., Washington, vol. 1, pp. 334–335.

    Google Scholar 

  66. Oxford, J.S. (1975): Specific Inhibitors of Influenza Virus Replication as Potential Chemoprophylactic Agents. - J. Antimicrob. Chemother., 1: 7–23.

    Google Scholar 

  67. Patki, A.S., Gupta, P. (1982): Chemotherapy, 28: 298–303.

    Google Scholar 

  68. Potter, C.W., Phair, J.P., Vodinelich, L., Fenton, R., Jennings, R. (1976): Antiviral Immunosuppressive and Antitumor Effects of Ribavirin. - Nature, 259: 406–497.

    Google Scholar 

  69. Povey, R.C. (1978): In Vitro Antiviral Efficacy of Ribavirin Against Feline Calicivirus, Feline Viral Rhinotracheitis Virus, and Canine Parainfluenza Virus. - Am. J. Vet. Res., 39: 175–178.

    Google Scholar 

  70. Renis, H.E. (1977): Influenza Virus Infection of Hamsters. A Model for Evaluating Antiviral Drugs.- Arch. Virol., 54: 85–93.

    Google Scholar 

  71. Salido-Rengell, F., Nasser-Quinones, H., Briseno-GarciaB. (1977): Clinical Evaluation of 1-β-D-Ribofuranosyl-1,2,4-Triazole-3-Carboxamide (Ribavirin) in a Double Blind Study During an Outbreak of Influenza. - Ann. N.Y. Sci., 284: 272–27.

    Google Scholar 

  72. Scheffler, P., Haghchenas, D., Wigand, R. (1975): The Effect of Purine and Pyrimidine Analogues and Virazole on Adenovirus Replication. - Acta. Virol., 19: 106–115.

    Google Scholar 

  73. Schiff, G.M., Stephens, K., Brooks, S., Cassidy, K., Odeski, R., Majors, M. (1984): Small Particle Aerosol of Ribavirin in the Therapy of Influenza —Cincinnati Study. In: Smith, R.A., Knight, V., and Smith, J.A.D. (eds), Clinical Applications of Ribavirin.- Academic Press, New York, pp. 145–153.

    Google Scholar 

  74. Schofield, K.P., Potter, C.W., Edey, D., Jennings, R., Oxford, J.S. (1975): Antiviral Activity of Ribavirin on Influenza Infection in Ferrets. - J. Antimicrob. Chemother. [Suppl], 1: 63–69.

    Google Scholar 

  75. Schoub, B.D., Prozesky, O.W. (1977): Antiviral Activity of Ribavirin in Rotavirus Gastroenteritis of Mice. - Antimicrob. Agents Chemoter., 12: 543–544.

    Google Scholar 

  76. Schulman, N.R. (1984): Assessment of Hematologic Effects of Ribavirin in Humans. In: Smith, R.A., Kirkpatrick, W., (eds), Ribavirin: A Broad Spectrum Antiviral Agent. - Academic Press, New York, pp. 79–92.

    Google Scholar 

  77. Shannon, W.M. (1977): Selective Inhibition of RNA Tumor Virus Replication In Vitro and Evaluation of Candidate Antiviral Agents In Vivo. - Ann. N.Y. Acad. Sci., 284: 472–507.

    Google Scholar 

  78. Shiota, H., Jones, B.R., Schaffner, C.P. (1977): Potential Role of Amphotericin B. Methyl Ester in the Prevention and Therapy of Herpetic Keratitis.- Trans. Opthalmol. Soc. U.K., 97: 318–323.

    Google Scholar 

  79. Sidwell, R.W. (1977): Ribavirin: A Broad Spectrum Antiviral Having Clinical Usefulness. In: Likar M., (ed), New Trends in Microbiology. - Ljubljiana, Yugoslavia: Society of Yugoslav Microbiologists, pp. 367–400.

    Google Scholar 

  80. Sidwell, R.W. (1980): Ribavirin: In Vitro Antiviral Activity. In: Smith, R.A., Kirkpatrick, W., (eds), Ribavirin: A Broad Spectrum Antiviral Agent. -Academic Press, London, New York, pp. 23–42.

    Google Scholar 

  81. Sidwell, R.W., Huffman, J.H., Kahre, G.P., Allen, L.B., Witkowski, J.T., Robins, R.K. (1972): Broad Spectrum Antiviral Activity of Virazole: 1-β-D-Ribofuranosyl-1, 2, 4-Triazole-3-Carboxamide.- Science, 177: 705–706.

    Google Scholar 

  82. Sidwell, R.W., Allen, L.B., Khare, G.P., Huffman, J.H., Witkowski, J.T., Simon, L.N., Robins, R.K. (1973): Effect of 1-β-D-Ribofuranosyl-1, 2, 4-Triazole-3-Carboxamide (Virazole, ICN 1229) on Herpes and Vaccinia Keratitis and Encephalitis in Laboratory Animals. - Antimicrob. Agents Chemother., 3: 242–246.

    Google Scholar 

  83. Sidwell, R.W., Simon, L.N, Witkowski, J.T., RobinsR.K. (1974): Antiviral Activity of Virazole: Review and Structure-Activity Relationships. In: Daikos G.K. (ed), Progress in Chemotherapy. - Athens: Hellenic Society for Chemotherapy, 2: 889–902.

    Google Scholar 

  84. Sidwell, R.W., Allen, L.B., Huffman, J.H., WitkowskiJ.T., Simon, L.N. (1975): Effect of 1-β-D-Ribofuranosyl-1,2,4-Triazole-3-Carboxamide (Ribavirin) on Friend Leukemia Virus Infections in Mice. - Proc. Soc. Exp. Biol. Med. 148: 854–858.

    Google Scholar 

  85. Sidwell, R.W., Khare, G.P., Allen, L.B., Huffman, J.H., Witkowski, J.T., Simon, L.N., Robins, R.K. (1975): In Vitro and In Vivo Effect on 1-β-D-Ribofuranosyl-1,2,4-Triazole-3-Carboxamide (Ribavirin) and Types 1 and 3 Parainfluenza Virus Infections.- Chemotherapy, 21: 205–220.

    Google Scholar 

  86. Sidwell, R.W., Robins, R.K., Hillyard, I.W. (1979): Ribavirin: An Antiviral Agent. Pharmacol. Ther., 6: 123–146.

    Google Scholar 

  87. Smith, C.B., Charette, R.P., Fox, J.P.Cooney, M.K., Hall, C.E. (1980): Double-Blind Evaluation of Ribavirin in Naturally Occurring Influenza. In: Smith, R.A., Kirkpatrick, W. (eds), Ribavirin: A Broad Spectrum Antiviral Agent. - Academic Press, London, New York, pp. 147–164.

    Google Scholar 

  88. Smith, R.A. (1980): Mechanisms of Action of Ribavirin. In: Smith, R.A., Kirkpatrick, W. (eds), Ribavirin: A Broad Spectrum Antiviral Agent. -Academic Press, London, New York, pp. 99–118.

    Google Scholar 

  89. Smith, R.A. (1984): Ribavirin. In: Becker, Y. (ed), Antiviral Drugs and Interferon: The Molecular Basis of Their Activity. - Martinus Nijhoff Pushing, Boston, pp. 253–269.

    Google Scholar 

  90. Smith R.A., Fernandez H., Banks G. (1985): Aerosolized Ribavirin Treatment of Immunodeficient Infants with. Respiratory Viral Infection. First International TNO Conference on Ativiral Research, Rotterdam, April 30 – May 3, 1985, (in press).

  91. Stephen, E.L., Jones, D.E., Peters, C.J., Eddy, G.A., Loizeaux, P.S., Jahrling, P.B. (1980): Ribavirin Treatment of Toga-, Arena-, and Bunyavirus Infections in Subhuman Primates and Other Laboratory Animal Species. In: Smith, R.A., Kirkpatrick W. (eds), Ribavirin: A Broad Spectrum Antiviral Agent. - Academic Press, London, New York, pp. 169–183.

    Google Scholar 

  92. Streeter, D.G., Witkowski, J.T.Khare, G.P., SidwellR.W., Bauer, R.J., Robins, R.K., Simon, L.N. (1973): Mechanism of Action of 1-β-D-Ribofuranosyl-1, 2, 4-Triazole-3-Carboxamide (Virazole), A New Broad Spectrum Antiviral Agent. - Proc. Natl. Acad. Sci. U.S.A., 70: 1174–1178.

    Google Scholar 

  93. Streeter, D.G., Simon, L.N., Robins, R.H., Miller, J.P. (1974): The Phosphorylation of Ribavirin by Deoxyadenosine Kinase From Rat Liver. - Differentiation Between Adenosine and Deoxyadenosine Kinase. - Biochemistry, 13: 453–459.

    Google Scholar 

  94. Suarez, S.F.Guevara, S.I., Mijangos, V.G. (1984): Treatment of Type A Hepatitis with Ribavirin. In: Smith, R.A., Knight, V., Smith, J.A.D. (eds), Clinical Applications of Ribavirin. - Academic Press, New York, pp. 193–201.

    Google Scholar 

  95. Suganuma, T., Ishida, N. (1973): An Evaluation of a New Antiviral Agent. ≪ Virazole ≫ Against Influenza Virus Infections. - Tohoku, J. Exp. Med., 110: 405–406.

    Google Scholar 

  96. Sung, K.J.Kim, K.J., Cinn, Y.W., Kim, W.S., KimH.S., Lee, H.S. (1980): Korean J. Derm., 18: 573–577.

    Google Scholar 

  97. Taber, L.H., Knight, V., Gilbert, B.E., McClung, H.W., Wilson, S.Z., Norton, H.J., Thurson, J.M., GordonW.H.Atmar, R.L., Schlaudt, W.R. (1983): Ribavirin Aerosol Treatment of Bronchiolitis Associated With Respiratory Syncytial Virus Infection in Infants. - Ped. 72(5): 613–618.

    Google Scholar 

  98. Tisdale, M., Bauer, D.J. (1975): A Comparison of Test Methods in Influenza Chemotherapy. - J. Antimicrob. Chemotherapy. - [Suppl.], 1: 55–62. ther., 4: 641–642.

    Google Scholar 

  99. Tisdale, M., Bauer, D.J. (1977): The Relative Potencies of Anti-Influenza Compounds. - Ann. N.Y. Acad. Sci., 284: 254–263.

    Google Scholar 

  100. Togo, Y. (1973): In Vitro Effect of Virazole Against Influenza Viruses. - Antimicrob. Agents Chemother., 4: 641–642.

    Google Scholar 

  101. Togo, Y., McCracken, E.D. (1976): Double Blind Assessment of Ribavirin (Virazole) in the Prevention and Treatment of Induced Infection With Type B Influenza Virus. - J. Infect. Dis., [Suppl], 133: A109-A113.

    Google Scholar 

  102. Wannarka, G.L., Stephen, E.L. and Canonico, P.G. (1982): Preclinical Evaluation in Monkeys of a Ribavirin Regimen Proposed for Use in Lassa Fever Patient. - Toxicol. Appl. Pharmacol., 64: 155–169.

    Google Scholar 

  103. White, H.A. (1972): Clinical Findings in 23 Cases of Lassa Fever Hospitalized in Jos, Nigeria, 1970. -Trans. R. Soc. Trop. Med. Hyg., 66: 390–399.

    Google Scholar 

  104. Williams, R.H., Gerzon, K., Hoehn, M., Gorman, M., Delong, D.C. (1969): Pyrazofurin, a Viral Carbolinked Nucleoside. In: Proc. 158th Am. Chem. Soc. Natl. Meet Abstr. MICR 38, New York, N.Y.

    Google Scholar 

  105. Willis, R.C., Carson, D.A., Seegmiller, J.E. (1978): Adenosine Kinase Initiates the Major Route of Ribavirin Activation in a Cultured Human Cell Line. - Proc. Nat. Acad. Sci U.S.A., 75: 3042–3044.

    Google Scholar 

  106. Witkowsky, J.T., Robins, R.K.Sidwell, R.W.SimonL.N. (1972): The Design, Synthesis and Broad Spectrum Antiviral Activity of 1-β-D-Ribofuranosyl-1,2,4-Triazole-3-Carboxamide and Related Nucleosides.- J. Med. Chem., 15: 1150–1156.

    Google Scholar 

  107. Zimmerman, T.P., Deeprose, R.D. (1978): Metabolism of 5-Amino-l-D-Ribofuranosylimidazole-4-Carboxamide and Related Five-Membered Heterocycles to 5′-Triphosphates in Human Blood and L5178Y Cells. - Biochem. Pharmacol., 27: 709–716.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Drug Development and Clinical Research, Viratek, Inc., 92626, Costa Mesa, California

    H. Fernandez, G. Banks & R. Smith

Authors
  1. H. Fernandez
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. G. Banks
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. R. Smith
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Corresponding author.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fernandez, H., Banks, G. & Smith, R. Ribavirin: A clinical overview. Eur J Epidemiol 2, 1–14 (1986). https://doi.org/10.1007/BF00152711

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00152711

Key words

Search

Navigation